$KROS Keros Therapeutics, Inc. Insider Trading Week 46/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Keros Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Keros Therapeutics, Inc. in week 46/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2020 | KROS | Keros Therapeutics ... | Nussbaum Ran | Director | Buy | P | 50.00 | 6,000 | 300,000 | 155,262 | 149.3 K to 155.3 K (+4.02 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Nussbaum Ran | Director | Buy | P | 50.00 | 14,400 | 720,000 | 1,228,326 | 1.2 M to 1.2 M (+1.19 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Nussbaum Ran | Director | Buy | P | 50.00 | 12,966 | 648,300 | 1,122,768 | 1.1 M to 1.1 M (+1.17 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Nussbaum Ran | Director | Buy | P | 50.00 | 26,634 | 1,331,700 | 2,288,151 | 2.3 M to 2.3 M (+1.18 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 6,000 | 300,000 | 155,262 | 149.3 K to 155.3 K (+4.02 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 14,400 | 720,000 | 1,228,326 | 1.2 M to 1.2 M (+1.19 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 12,966 | 648,300 | 1,122,768 | 1.1 M to 1.1 M (+1.17 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 26,634 | 1,331,700 | 2,288,151 | 2.3 M to 2.3 M (+1.18 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 6,000 | 300,000 | 155,262 | 149.3 K to 155.3 K (+4.02 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 14,400 | 720,000 | 1,228,326 | 1.2 M to 1.2 M (+1.19 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 12,966 | 648,300 | 1,122,768 | 1.1 M to 1.1 M (+1.17 %) |
| Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 26,634 | 1,331,700 | 2,288,151 | 2.3 M to 2.3 M (+1.18 %) |